FIN STREET SEC (01476): Zhu Yanhui and Yin Guohong Appointed as Executive Directors
FIN STREET SEC (01476) announced that, with the approval of shareholders at the extraordinary general meeting, Mr. Zhu Yanhui and Mr. Yin Guohong were appointed as executive directors of the sixth board of directors; Mr. Pang Jiemin, Mr. Luo Guohua, Mr. Li Yanyong and Mr. Xie Xin were appointed as non-executive directors of the sixth board of directors; and Ms. Cheng Zhuo, Mr. Fan Xiaoxin, Mr. Wang Jinyong and Mr. Cao Liang were appointed as independent non-executive directors of the sixth board of directors.
FIN STREET SEC (01476) announced that, with shareholder approval at the extraordinary general meeting, Mr. Zhu Yanhui and Mr. Yin Guohong have been appointed as executive directors of the sixth session of the board of directors; Mr. Pang Jiemin, Mr. Luo Guohua, Mr. Li Yanyong and Mr. Xie Xin have been appointed as non-executive directors of the sixth session of the board of directors; and Ms. Cheng Zhuo, Mr. Fan Xiaoxin, Mr. Wang Jinyong and Mr. Cao Liang have been appointed as independent non-executive directors of the sixth session of the board of directors.
Mr. Chen Xin, Mr. Qi Liang and Mr. Xu Hongcai have retired from their directorships, effective from the date of the extraordinary general meeting.
The Company convened an employee representative meeting on October 22, 2026, at which the election of Mr. Zhou Lijun as an employee representative director (employee representative director) (non-executive director) of the sixth session of the board of directors was deliberated and approved, with his term of office the same as the term of the sixth session of the board of directors.
After the extraordinary general meeting, the board of directors convened the first meeting of the sixth session of the board of directors on the same day, at which Mr. Zhu Yanhui was appointed as the chairman of the sixth session of the board of directors, with his term of office the same as the term of the sixth session of the board of directors.
At the first meeting of the board of directors, the board resolved to appoint the members of the Strategy and Investment Decision Committee of the sixth session of the board of directors, the Risk Control and Supervision Committee of the sixth session of the board of directors, the Audit Committee of the sixth session of the board of directors and the Remuneration and Nomination Committee of the sixth session of the board of directors.
The Strategy and Investment Decision Committee is composed of Mr. Zhu Yanhui, Mr. Yin Guohong, Mr. Pang Jiemin, Mr. Wang Jinyong and Mr. Cao Liang. Mr. Zhu Yanhui has been appointed as the chairman of the committee.
The Risk Control and Supervision Committee is composed of Mr. Zhu Yanhui, Mr. Luo Guohua and Mr. Li Yanyong. Mr. Zhu Yanhui has been appointed as the chairman of the committee.
The Audit Committee is composed of Ms. Cheng Zhuo, Mr. Luo Guohua, Mr. Fan Xiaoxin, Mr. Cao Liang and Mr. Zhou Lijun. Ms. Cheng Zhuo has been appointed as the chairman of the committee.
The Remuneration and Nomination Committee is composed of Mr. Wang Jinyong, Mr. Xie Xin and Ms. Cheng Zhuo. Mr. Wang Jinyong has been appointed as the chairman of the committee.
At the first meeting of the board of directors, the board agreed to appoint Mr. Yin Guohong as the president of the Company, with his term of office from the date of approval by the first meeting of the board of directors until the expiration of the term of the sixth session of the board of directors.
At the first meeting of the board of directors, the board agreed to appoint Ms. Yu Lei as the vice president and chief financial officer of the Company, to appoint Mr. Zhang Wei, Ms. Yang Shufei, Mr. Tang Jun and Mr. Yang Jinliang as vice presidents of the Company, to appoint Mr. Zhang Jingshun as the secretary of the board of directors of the Company, to appoint Mr. Liu Zhanjun as the chief compliance officer and chief risk officer of the Company, and to appoint Mr. Cheng Wendong as the chief information officer of the Company. The terms of office of the above senior management personnel shall all be from the date of approval by the first meeting of the board of directors until the expiration of the term of the sixth session of the board of directors.
Related Articles

CHENGDU EXPWAY (01785): Chengdu-Wenjiang-Qionglai Expressway Company and China Railway Baoji Bridge Sign Steel Structure Construction GJG Section Contract

BEAUTYFARM MED (02373) repurchased 31,000 shares on October 23 for HK$523,400.

Industrial capital and global automakers join forces to back XHEART New Core Journey's completion of strategic round financing.
CHENGDU EXPWAY (01785): Chengdu-Wenjiang-Qionglai Expressway Company and China Railway Baoji Bridge Sign Steel Structure Construction GJG Section Contract

BEAUTYFARM MED (02373) repurchased 31,000 shares on October 23 for HK$523,400.

Industrial capital and global automakers join forces to back XHEART New Core Journey's completion of strategic round financing.






